A detailed history of Ghost Tree Capital, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 190,000 shares of JANX stock, worth $10.8 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares
190,000
Previous 50,000 280.0%
Holding current value
$10.8 Million
Previous $2.09 Million 312.18%
% of portfolio
3.23%
Previous 0.85%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$35.29 - $50.26 $4.94 Million - $7.04 Million
140,000 Added 280.0%
190,000 $8.63 Million
Q2 2024

Aug 14, 2024

BUY
$35.12 - $64.78 $1.76 Million - $3.24 Million
50,000 New
50,000 $2.09 Million

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.36B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.